Anders Kronström

Title: The Innovations of Anders Kronström

Introduction

Anders Kronström is a notable inventor based in Stockholm, Sweden. He has made significant contributions to the field of pharmaceuticals, particularly in the development of novel processes and compounds. With a total of 3 patents, his work has had a meaningful impact on the industry.

Latest Patents

Kronström's latest patents include a novel process for the preparation of the magnesium salt of the (−)-enantiomer of 5-methoxy-2-[[(4-methoxy-3,5-dimethyl-2-pyridinyl)-methyl]sulfinyl]-1-benzimidazole trihydrate, known as S-omeprazole magnesium salt trihydrate. This invention not only details the preparation process but also includes pharmaceutical compositions containing the magnesium salt. Another significant patent involves a novel form of the (−)-enantiomer of 5-methoxy-2-[[(4-methoxy-3,5-dimethyl-2-pyridinyl)-methyl]sulfinyl]-1-benzimidazole, specifically the magnesium salt of the S-enantiomer of omeprazole trihydrate. This patent also outlines processes for preparing this form and the pharmaceutical compositions that utilize it.

Career Highlights

Anders Kronström is associated with AstraZeneca AB, a leading global biopharmaceutical company. His work at AstraZeneca has allowed him to focus on innovative pharmaceutical solutions that address various health challenges. His contributions have been instrumental in advancing the company's research and development efforts.

Collaborations

Kronström has collaborated with several talented individuals in his field, including Anders Mattson and Eva Leander. These collaborations have fostered a creative environment that encourages the exchange of ideas and the development of groundbreaking inventions.

Conclusion

Anders Kronström's innovative work in the pharmaceutical industry exemplifies the importance of research and development in creating effective medical solutions. His patents and collaborations highlight his commitment to advancing healthcare through innovation.